Yung Hyup Joo,Heung Soo Baek,Jeong Hwan Kim,Chang Geun Yi,Hyung Jun Lim,Hong-Ju Shin,Yongjin Kim,Jon Hwan Lee
申请号：
US15085628
公开号：
US09433593B1
申请日:
2016.03.30
申请国别(地区):
US
年份:
2016
代理人:
摘要：
5-Adamantan-1-yl-N-(2,4-dihydroxybenzyl)-2,4-dimethoxybenzamide disclosed in the present disclosure lacks toxicity and can exhibit superior anti-inflammatory effect. It exhibits superior anti-inflammatory effect, for example, by inhibiting the production of one or more of NO and PGE2, by inhibiting the activity of one or more of the transcription factors NF-κB and AP-1 or by inhibiting proinflammatory cytokines such as IL-1β.
